EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest

Sema Atasever

International Journal of Molecular Sciences · 17.03.2025 · 26 (6) · 2680

DOI: 10.3390/ijms26062680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2025. Verfasst von Sema Atasever. Beteiligte Einrichtung: Department of Computer Engineering, Faculty of Engineering and Architecture, Nevsehir Haci Bektas Veli University, 50300 Nevşehir, Turkey. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, Antiviral Agents, Hepacivirus, Protease Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The classification of Hepatitis C virus (HCV) NS3 inhibitors is essential for identifying potential antiviral agents through computational methods. This study aims to develop an optimized machine learning (ML) model using random forest (RF) and molecular fingerprints to accurately classify HCV NS3 inhibitors. A dataset of 965 molecules was retrieved from the ChEMBL database, and 290 bioactive compounds were selected for model training. Twelve molecular fingerprint descriptors were tested, and the CDK graph-only fingerprint yielded the best performance. In addition to RF, performance comparisons of other classifiers such as instance-based k-nearest neighbor (IBk), logistic regression (LR), AdaBoost, and OneR were conducted using WEKA with various molecular fingerprint descriptors. The optimized RF model achieved an accuracy of 89.6552%, a mean absolute error (MAE) of 0.2114, a root mean square error (RMSE) of 0.3304, and a Matthews correlation coefficient (MCC) of 0.7950 on the test set. These results highlight the effectiveness of optimized molecular fingerprints in enhancing virtual screening (VS) for HCV inhibitors. This approach offers a data-driven method for drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral Nonstructural ProteinsAntiviral AgentsHepacivirusProtease InhibitorsMachine LearningHumansDrug DiscoveryHepatitis CRandom ForestViral ProteasesSerine EndopeptidasesNucleoside-TriphosphataseDEAD-box RNA Helicases

Stichwörter der Autor:innen

HCV NS3 inhibitorsQSARcomputational drug designmachine learningmolecular descriptor optimization

Substanzen

Viral Nonstructural ProteinsAntiviral AgentsNS3 protein, hepatitis C virusProtease InhibitorsViral ProteasesSerine EndopeptidasesNucleoside-TriphosphataseDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Computer Engineering, Faculty of Engineering and Architecture, Nevsehir Haci Bektas Veli University, 50300 Nevşehir, Turkey.

Zitieren

APA

Atasever, S. (2025). Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest. International Journal of Molecular Sciences, 26(6), 2680. https://doi.org/10.3390/ijms26062680

Vancouver

Atasever S. Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest. International Journal of Molecular Sciences. 2025;26(6):2680. doi:10.3390/ijms26062680

BibTeX
@article{Atasever2025,
  author = {Atasever, Sema},
  title = {Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2680},
  doi = {10.3390/ijms26062680}
}
Kostenlos starten →